Comparative Quantification of Plasma hnRNP B1 mRNA in Non-small Cell Lung Cancer Patients by Real-time PCR;Korean Source Real-time PCR Korean Source Heterogeneous Ribonucleoprotein B1 mRNA Korean Source

Korean Journal of Laboratory Medicine

Volumn 29, Issue 3, 2009, Pages 249-255

  Kim, Jeong Man ^a   Hwang, Sang Hyun ^b,c   Song, Eun Ju ^b   Sang Yull, Lee ^c   Kim, Yeong Dae ^c   Lee, Chang Hun ^c   Lee, Min Ki ^c   Chang, Chulhun L ^b,c   Lee, Eun Yup ^b,c  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Cancer biomarker; Circulating nucleic acid; HnRNP B1; Lung cancer; Plasma mRNA

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-B1; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 70349309358     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.3.249     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. National Cancer Informastion Center. Cancer incidence. http://www.cancer.go.kr/cms/statics/incidence/index.html. (Updated on Jun 2008).
3. Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000;89:2356-62.
4. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999;5:1961-5.
5. Zhou J, Mulshine JL, Unsworth EJ, Scott FM, Avis IM, Vos MD, et al. Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem 1996;271:10760-6.
6. Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, et al. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 2001;945:179-88.
7. Sueoka E, Sueoka N, Iwanaga K, Sato A, Suga K, Hayashi S, et al. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer 2005;48:77-83.
8. Zech VF, Dlaska M, Tzankov A, Hilbe W. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 2006;30:395-402.
9. Sato A, Sueoka-Aragane N, Saitoh J, Komiya K, Hisatomi T, Tomimasu R, et al. Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer. J Cancer Res Clin Oncol 2008; 134:1191-7.
10. Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994;13:5483-95.
11. Livak KJ. Comparative Ct Method. ABI PRISM 7700 Sequence Detection System. User Bulletin No. 2. Relative Quantitation of Gene Expression. PE Applied Biosystems, 1997.
12. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50.
13. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001;61:4675-8.
14. Mulcahy HE, Lyautey J, Lederrey C, qi Chen X, Anker P, Alstead EM, et al. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998;4:271-5.
15. Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 2004;108:91-6.
16. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70.
17. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
18. Beau-Faller M, Gaub MP, Schneider A, Ducrocq X, Massard G, Gasser B, et al. Plasma DNA microsatellite panel as sensitive and tumorspecific marker in lung cancer patients. Int J Cancer 2003;105:361-70.
19. Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005;49:1-12.
20. Sozzi G, Conte D, Leon M, Cirincione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-8.
21. Bruhn N, Beinert T, Oehm C, Jandrig B, Petersen I, Chen XQ, et al. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer. Ann NY Acad Sci 2000;906:72-82.
22. Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res 2002;62:351-5.
23. Sueoka E, Sueoka N, Goto Y, Matsuyama S, Nishimura H, Sato M, et al. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res 2001;61:1896-902.
24. Wu S, Sato M, Endo C, Sakurada A, Dong B, Aikawa H, et al. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003;41:179-86.
25. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C[T]) Method. Methods 2001;25:402-8.
26. Matsuyama S, Goto Y, Sueoka N, Ohkura Y, Tanaka Y, Nakachi K, et al. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn J Cancer Res 2000;91:658-63.